Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-725-9 | CAS number: 13945-76-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames test (OECD 471, read across): negative with and without metabolic activation in S. typhimurium TA 1535, TA 1537, TA 1538, TA 100 and TA 98 and TA 102.
In vitro chromosome aberration (OECD 473, read across): negative in primary human peripheral lymphocytes with and without metabolic activation.
In vitro gene mutation in mammalian cells (OECD 476, read across): negative in mouse lymphoma L5178Y cells with and without metabolic activation.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 Nov 1999 - 13 Mar 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only 2-AA used as positive control in the presence of S9-mix
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- certified by the Hessische Ministerium für Umwelt, Energie, Jugend, Familie und Gesundheit
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his operon
- Species / strain / cell type:
- S. typhimurium, other: TA 1535, TA 1537, TA 98, TA 100
- Additional strain / cell type characteristics:
- other: rfa-; uvrB- (R+ for TA 98 and TA 100)
- Species / strain / cell type:
- S. typhimurium TA 102
- Additional strain / cell type characteristics:
- other: rfa-; uvrB+; R+
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital and β-naphthoflavone.
- Test concentrations with justification for top dose:
- Experiment 1 and 2: 33, 100, 333, 1000, 2500 and 5000 µg/plate
Experiment 2: 333, 1000, 2500 and 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO (MERCK, D-64293 Darmstadt; purity > 99%)
- Justification for choice of solvent/vehicle: The solvent was chosen because of its solubility properties and its relative nontoxicity to the bacteria. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 10 µg/plate sodium azide (TA 1535 and TA 100; -S9); 4-nitro-o-phenylene-diamine (10 µg/plate in TA 98 and 50 µg/plate in TA 1537; -S9); 5.0 µl/plate methylmethanesulfonate (TA 102; -S9); 2.5 µg/plate 2-aminoanthracene (10.0 µg/plate in TA 102) (+S9)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) (first experiment); preincubation (second and third experiment)
DURATION
- Preincubation period: 60 min
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: triplicates each in three independent experiments
DETERMINATION OF CYTOTOXICITY
- Method: Inspection of the bacterial background lawn - Evaluation criteria:
- A test item is considered positve if either a dose related increase in the number of revertants or a biologically relevant increase for at least one test concentration is induced. A test item producing neither a dose related increase in the number of revertants nor a biologically relevant positive response at any one of the test points is considered non-mutagenic in the test system.
A biologically relevant response is described as follows:
A test item is considered mutagenic if the number of reversions is at least twice the spontaneous reversion rate in strains TA 98, TA 100 and TA 102 or thrice in strains TA 1535 and TA 1537. Also, a dose-dependent increase in the number of revertants is regarded as an indication of possibly existing mutagenic potential of the test item regardless whether the highest dose fulfilled the criteria described above or not. - Key result
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 98, TA 100, TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- COMPARISON WITH HISTORICAL CONTROL DATA: yes
- Conclusions:
- CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 25 Jul - 02 Aug 1990
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- incomplete strain selection
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Genes involved in Histidine synthesis
- Species / strain / cell type:
- S. typhimurium, other: TA 1535, TA 1537, TA 98, TA 100
- Species / strain / cell type:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254.
- Test concentrations with justification for top dose:
- 8, 40, 200, 1000 and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Tween 80/water (bidest.)
The suspension medium was choosen according to solubility properties tested in a preliminary experiment. - Untreated negative controls:
- yes
- Remarks:
- culture medium
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Tween 80
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- 2 µg/plate for TA 100 and TA 1535 without metabolic activation
- Untreated negative controls:
- yes
- Remarks:
- culture medium
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Tween 80
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- 80 µg/plate for TA 1537 without metabolic activation
- Untreated negative controls:
- yes
- Remarks:
- culture medium
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Tween 80
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 4-nitro-o-phenylendiamine
- Remarks:
- 40 µg/plate for TA 98 and TA 1538 without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- 2.5 µg/plate for TA 1535, TA 1537 and 5 µg/plate for TA 98, TA 100, TA 1538 (with S9 mix)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: Inspection of the bacterial background lawn
OTHER: The spontaneous mutation rates of each tester strain were within the characteristic spontaneous mutation rates - Evaluation criteria:
- The test material may be considered positive in this test system if the following criteria are met: For the test item to be considered mutagenic, two-fold (or more) increases in mean revertant numbers must be observed at two consecutive dose levels or at the highest practicable dose level only. In addition, there must be evidence of a dose-response relationship showing increasing numbers of mutant colonies with increasing dose levels.
All cultures must demonstrate the characteristic mean number of spontaneous revertants in the vehicle controls. - Statistics:
- Means and standard deviations were calculated
- Key result
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- COMPARISON WITH HISTORICAL CONTROL DATA: Yes
- Conclusions:
- CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 06 - 15 Sep 1989
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- No TA 102 or E.coli strains were tested.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- no TA 102 or E.coli strains were tested
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- yes
- Remarks:
- no TA 102 or E.coli strains were tested
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his operon
- Species / strain / cell type:
- S. typhimurium, other: TA 1535, TA 1537, TA 98, TA 100 and TA 1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- Cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with 500 mg/kg bw Aroclor 1254
- Test concentrations with justification for top dose:
- Experiment 1: 8, 40, 200, 1000 and 5000 µg/plate without metabolic activation; 16, 80, 400, 1000 and 5000 µg/plate with metabolic activation
Experiment 2: 8, 40, 200, 1000 and 5000 µg/plate with and without metabolic activation - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Tween 80/aqua bidest.
- Justification for choice of solvent/vehicle: the vehicle was chosen according to the solubility properties tested before the start of the study - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: sodium azide (2.5 µg/plate, ± S9, TA 100, TA 1535); 9 -aminoacridine (80 µg/plate, ± S9, TA 1537); 4 -nitro-o-phenylenediamine (40 µg/plate, ± S9, TA98, TA 1538); 2 -aminoanthracene (5.0 µg/plate ± S9, TA 1535, TA 1537; 2.5 µg/plate, ± S9, TA 98, TA 100)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Preincubation period: 12 h
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
OTHER: The test batches containing S9-mix were controlled for sterility by adding 0.5 ml S9-mix to untreated agar plates. The microsomal enzyme activity was examined with 2-amino-anthracene and benzo(a)pyrene on TA 98 and in a cytogenetic test with cyclophosphamide. - Evaluation criteria:
- A combination of the following criteria was considered as a positive result:
- The plate background of non-reverted bacteria did not show any growth reduction versus the respective negative controls
- The spontaneous mutation rates of each tester strain per plate were within the characteristic spontaneous mutation range (see Table 1 under 'any other information on materials and method including tables')
- As a rule, the positive control showed mutation rates exceding the control values of TA 100 at least by the factor 2.0 and those of the other tester strains at least by the factor 3.0
- At more than one dose tested, the test substance caused at least a 2.0 fold increase in comparison with the negative controls in the tester strain S. typhimurium TA 100. For the other tester strains used, an increase in the mutation rate of more than 3.0 above the corresponding negative controls was considered positive. - Key result
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 98, TA 100 and TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- COMPARISON WITH HISTORICAL CONTROL DATA: Yes, the spontaneous mutation rate of each tester strain per plate were within the characteristic spontaneous mutation range (see Table 1).
ADDITIONAL INFORMATION ON CYTOTOXICITY: cytotoxicity was observed at 5000 µg/plate - Conclusions:
- CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09 Apr - 10 May 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Target gene:
- Not applicable
- Species / strain / cell type:
- lymphocytes: cultured peripheral human lymphocytes
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9-mix
- Test concentrations with justification for top dose:
- 3, 10 and 33 µg/mL
At a concentration of 33 µg/mL and above precipitation was seen in the culture medium. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Ethanol
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with rat liver S9-mix; 10 µg/mL
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without rat liver S9-mix; 0.5 µg/mL for a 3 h exposure period, 0.2 µg/mL for a 24 h exposure period and 0.1 µg/mL for a 48 h exposure period
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 3, 24 and 48h
- Fixation time (start of exposure up to fixation or harvest of cells): 3h treatment: 24 and 48h; 24h treatment: 24h; 48h treatment: 48h
SPINDLE INHIBITOR (cytogenetic assays): colchicine 0.5 µL/mL medium
STAIN (for cytogenetic assays): Giemsa 5% (v/v) in tap water
NUMBER OF REPLICATIONS: 2 (duplicates at the 3h-exposure time)
NUMBER OF CELLS EVALUATED: 100 per culture
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index of 1000 cells
OTHER EXAMINATIONS:
- Determination of polyploidy: yes - Evaluation criteria:
- A test substance was considered positive (clastogenic) in the chromosome aberration test if: a) It induced a dose-related statistically significant (Chi-square test, one-sided, p < 0.05) increase in the number of cells with chromosome aberrations. b) A statistically significant and biologically relevant increase in the frequencies of the number of cells with chromosome aberrations was observed in the absence of a clear dose-response relationship.
A test substance was considered negative (not clastogenic) in the chromosome aberration test if none of the tested concentrations induced a statistically significant (Chi-square test, one-sided, p < 0.05) increase in the number of cells with chromosome aberrations. The preceding criteria are not absolute and other modifying factors might enter into the final evaluation decision. - Statistics:
- Chi-square test, one-sided, p < 0.05
- Key result
- Species / strain:
- lymphocytes: cultured human peripheral lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: At a concentration of 33 µg/mL 2-ethylhexyl oleate precipitated in the culture medium
- Other confounding effects: 2-ethylhexyl oleate showed no significant effects on the number of polyploid cells
RANGE-FINDING/SCREENING STUDIES: The highest concentration analysed was selected based on the solubility of the test substance in the culture medium (3 h and 24 h continuous exposure) or on toxicity, inhibition of the mitotic index of about 50% or greater (48 h continuous exposure).
ADDITIONAL INFORMATION ON CYTOTOXICITY:
No cytotoxicity was observed in the duplicate cultures of the 3h exposure time. - Conclusions:
- CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09 Apr - 27 Jul 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
- Target gene:
- Thymidine Kinase locus (TK gene)
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver microsomal enzymes were prepared from adult male Wistar rats which were treated with phenobarbital (89 mg/kg bw) and β-naphthoflavone (100 mg/kg bw).
- Test concentrations with justification for top dose:
- 0.03, 0.1, 0.3, 1, 3, 10, 33, 100 µg/mL
Precipitation in the exposure medium was seet at concentrations of 100 µg/mL and above. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Ethanol
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- With metabolic activation; 7.5 µg/mL
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- Without metabolic activation; 15 and 5 µg/mL for a 3 and 24 hours treatment period
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
For 3-hour exposure: Cells were exposed to the test substance in basic medium supplemented with 5% (v/v) heat-inactivated horse serum.
For 24-hour exposure: Cells were exposed to the test substance in basic medium supplemented with 10% (v/v) heat-inactivated horse serum.
Selective medium consisted of basic medium supplemented with 20% (v/v) heat-inactivated horse serum (total amount of serum = 20%, R20) and 5 µg/mL trifluorothymidine (TFT). Non selective medium consisted of basic medium supplemented with 20% (v/v) heat-inactivated horse serum (total amount of serum = 20%, R20) .
DURATION
- Exposure duration: In experiment 1 - 3 hours. Experiment 2 - 24 hours (- S9 mix) and 3 hours (+S9)
- Expression time (cells in growth medium): 2 days
- Selection time (if incubation with a selection agent): 11-12 days
SELECTION AGENT (mutation assays): Trifluorothymidine (TFT)
STAIN (for cytogenetic assays): 0.5 mg/mL of 3-[4,5-dimethylthiazol-2-yl]-2-yl]-2,5- diphenyltetrazolium bromide (MTT).
NUMBER OF REPLICATIONS: 1
NUMBER OF CELLS EVALUATED: Whole wells counted
DETERMINATION OF CYTOTOXICITY
- Method: Relative total growth - Evaluation criteria:
- In addition to the criteria stated below, any increase of the mutation frequency will be evaluated for its biological relevance including a comparison of the results with the historical control data range.
The global evalulation factor (GEF) has been defined by the IWTG as the mean of the negative/solvent MF distribution plus one standard deviation. For the micro well version of the assay the GEF is 126.
A test substance is considered postive (mutagenic) in the mutation assay if it induces a mutation factor (MF) of more than MF(control) + 126 in a dose-dependent manner. An observed increase should be biologically relevant and will be compared with the historical control data range. The test substance will be considered equivocal (questionable) in the mutation assay if no clear conclusion for positive or negative result can be made after an additional confirmation study.
Thes test substance is considered negative (not mutagenic) in the mutation assay if:
a) None of the tested concentrations reaches a mutation frequency of MF(controls) + 126.
b) The resullts are confirmed in an indepedently repeated test.
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: 2-Ethylhexyl oleate was tested beyond the limit of the solubility to obtain adequate cytotoxicity data, the concentration used as the highest test substance concentration for the dose range finding test was 333 µg/mL.
- Precipitation: 2-Ethylhexyl oleate precipitated in the exposure medium at concentrations of 100 µg/mL and above.
RANGE-FINDING/SCREENING STUDIES: In the dose finding test, L5178Y mouse lymphoma cells were treated with a test substance concentration range of 3 to 333 µg/mL in the absence of S9-mix with a 3 and 24-hour treatment period and in the presence of S9-mix with a 3-hour treatment period.
After 3 hours treatment and 24 and 48 hours subculture, no toxicity in the suspension growth was observed up to and including the highest test substance concentration of 333 µg/mL compared to the suspension growth of the solvent control both in the absence of S9-mix and presence of S9-mix.
After 24 hours of treatment and 24-hour subculture, in the absence of S9-mix, no toxicity in the relative suspension growth was observed up to test substance concentration of 333 µg/mL compared to the solvent control.
COMPARISON WITH HISTORICAL CONTROL DATA: The spontaneous mutation frequencies in the solvent-treated control cultures were between the
minimum and maximum value of the historical control data range. See Table 1 to 4. - Conclusions:
- CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
Referenceopen allclose all
Table 1. Test results without S9-mix
Without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates; 2 or 3 independent experiments) |
||||||||||
Base-pair substitution type |
Frameshift type |
|||||||||||
TA 100 |
TA1535 |
TA102 |
TA98 |
TA1537 |
||||||||
Experiment |
I |
II |
I |
II |
III |
I |
II |
I |
II |
I |
II |
|
|
0 |
132 |
58 |
19 |
11 |
26 |
184 |
208 |
27 |
15 |
24 |
18 |
– |
Solvent control |
114 |
62 |
16 |
13 |
26 |
152 |
201 |
26 |
14 |
24 |
22 |
– |
33 |
104 |
69 |
11 |
12 |
- |
173 |
198 |
25 |
14 |
28 |
24 |
– |
100 |
123 |
71 |
17 |
12 |
- |
167 |
191 |
25 |
10 |
27 |
22 |
– |
333 |
127 |
68 |
23 |
12 |
25 |
178 |
280 |
20 |
13 |
30 |
23 |
– |
1000 |
117 |
58 |
14 |
26 |
25 |
169 |
183 |
23 |
13 |
31 |
21 |
– |
2500 |
115 |
68 |
16 |
35 |
23 |
119 |
266 |
20 |
7 |
23 |
25 |
– |
5000 |
122 |
63 |
16 |
32 |
25 |
176 |
270 |
22 |
11 |
23 |
20 |
Positive controls, –S9 |
Name |
SA |
SA |
MMS |
4NOPD |
4NOPD |
||||||
Concentrations (μg/plate) |
10.0 |
10.0 |
5 µL/plate |
10.0 |
50.0 |
|||||||
Mean No. of colonies/plate (average of 3) |
1490 |
1150 |
1075 |
1210 |
760 |
1387 |
1270 |
389 |
250 |
86 |
95 |
Table 2. Test results with S9-mix
With S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates; 2 independent experiments) |
||||||||||
Base-pair substitution type |
Frameshift type |
|||||||||||
TA 100 |
TA1535 |
TA102 |
TA98 |
TA1537 |
||||||||
Experiment |
I |
II |
I |
II |
III |
I |
II |
I |
II |
I |
II |
|
+ |
0 |
143 |
96 |
8 |
11 |
- |
192 |
227 |
45 |
26 |
26 |
20 |
+ |
Solvent control |
129 |
70 |
10 |
10 |
- |
154 |
215 |
36 |
19 |
31 |
22 |
+ |
33 |
118 |
72 |
9 |
8 |
- |
144 |
201 |
46 |
20 |
28 |
24 |
+ |
100 |
118 |
76 |
8 |
9 |
- |
166 |
219 |
46 |
24 |
34 |
24 |
+ |
333 |
131 |
80 |
6 |
10 |
- |
170 |
220 |
41 |
17 |
32 |
26 |
+ |
1000 |
125 |
50 |
9 |
6 |
- |
186 |
211 |
49 |
17 |
26 |
17 |
+ |
2500 |
122 |
75 |
5 |
8 |
- |
154 |
172 |
55 |
17 |
23 |
28 |
+ |
5000 |
128 |
77 |
11 |
6 |
- |
153 |
217 |
45 |
22 |
33 |
27 |
Positive controls, +S9 |
Name |
2-AA |
2-AA |
2-AA |
2-AA |
2-AA |
||||||
Concentrations (μg/plate) |
2.5 |
2.5 |
10.0 |
2.5 |
2.5 |
|||||||
Mean No. of colonies/plate (average of 3) |
1803 |
536 |
231 |
151 |
- |
726 |
1497 |
892 |
536 |
117 |
169 |
SA = Sodium azide
4NOPD = 4-nitro-o-phenylene-diamine
MMS = Methyl methane sulfonate
2-AA = 2-Aminoanthracene
Table 1: Mutagenicity on bacteria - experiment I
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates) |
||||
TA 1535 |
TA100 |
TA1537 |
TA1538 |
TA98 |
||
- |
Buffer |
8 |
102 |
10 |
11 |
30 |
- |
Solvent (Tween80/H2O) |
7 |
99 |
9 |
8 |
29 |
- |
8 |
4 |
110 |
9 |
10 |
28 |
- |
40 |
6 |
100 |
11 |
6 |
32 |
- |
200 |
12 |
112 |
8 |
10 |
28 |
- |
1000 |
12 |
97 |
10 |
11 |
31 |
- |
5000 |
9 |
106 |
9 |
11 |
30 |
Positive controls - S9 |
Name |
SA |
SA |
9AA |
4ND |
4ND |
Concentrations (μg/plate) |
2 |
2 |
80 |
40 |
40 |
|
Number of colonies/plate |
297 |
311 |
413 |
1677 |
830 |
|
+ |
Buffer |
6 |
93 |
8 |
14 |
26 |
+ |
Solvent (Tween80/H2O) |
8 |
94 |
8 |
12 |
37 |
+ |
8 |
7 |
94 |
7 |
21 |
36 |
+ |
40 |
8 |
104 |
8 |
10 |
35 |
+ |
200 |
6 |
97 |
9 |
12 |
37 |
+ |
1000 |
8 |
97 |
7 |
9 |
40 |
+ |
5000 |
6 |
95 |
7 |
13 |
37 |
Positive controls + S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
2.5 |
5 |
2.5 |
5 |
5 |
|
Number of colonies/plate |
107 |
1870 |
208 |
1566 |
1720 |
9AA = 9-Aminoacridine
2AA = 2-Aminoanthracene
SA = Sodium Acide
4ND = 4-Nitro-o-phenylendiamine
Table 2: Mutagenicity on bacteria - experiment II
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates) |
||||
TA 1535 |
TA100 |
TA1537 |
TA1538 |
TA98 |
||
|
Buffer |
9 |
99 |
7 |
9 |
30 |
- |
Solvent (Tween80/H2O) |
11 |
100 |
9 |
10 |
32 |
- |
8 |
8 |
101 |
8 |
11 |
33 |
- |
40 |
6 |
105 |
7 |
10 |
37 |
- |
200 |
9 |
112 |
8 |
11 |
37 |
- |
1000 |
8 |
107 |
10 |
12 |
39 |
|
5000 |
13 |
100 |
11 |
10 |
32 |
Positive controls - S9 |
Name |
SA |
SA |
9AA |
4ND |
4ND |
Concentrations (μg/plate) |
2 |
2 |
80 |
40 |
40 |
|
Number of colonies/plate |
270 |
270 |
296 |
1648 |
1359 |
|
+ |
Buffer |
9 |
108 |
9 |
11 |
35 |
+ |
Solvent (Tween80/H2O) |
11 |
104 |
11 |
14 |
30 |
+ |
8 |
7 |
105 |
9 |
13 |
32 |
+ |
40 |
8 |
105 |
9 |
11 |
32 |
|
200 |
7 |
121 |
5 |
11 |
38 |
+ |
1000 |
8 |
120 |
8 |
14 |
32 |
+ |
5000 |
7 |
112 |
7 |
10 |
41 |
Positive controls + S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
2.5 |
5 |
2.5 |
5 |
5 |
|
Number of colonies/plate |
137 |
1774 |
253 |
1419 |
1810 |
9AA = 9-Aminoacridine
2AA = 2-Aminoanthracene
SA = Sodium Acide
4ND = 4-Nitro-o-phenylendiamine
Table 2: Test results of experiment 1
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± SD) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA 1535 |
TA 1538 |
TA 98 |
TA 1537 |
||
Negative controls, –S9 |
Culture medium and Tween 80/aqua bidest. |
64.4 ± 11.4 |
10.0 ± 3.5 |
9.6 ± 2.9 |
23.8 ± 3.1 |
5.5 ± 1.3 |
– |
8 |
67.6 ± 4.5 |
13.3 ± 2.5 |
10.0 ± 1.0 |
29.0 ± 4.3 |
9.6 ± 2.8 |
- |
40 |
78.3 ± 12.0 |
9.0 ± 4.0 |
10.0 ± 1.0 |
29.3 ± 1.5 |
5.0 ± 2.6 |
- |
200 |
79.5 ± 23.3* |
7.0 ± 3.0 |
9.6 ± 2.5 |
22.6 ± 4.7 |
8.0 ± 6.0 |
– |
1000 |
80.6 ± 17.0 |
8.6 ± 3.5 |
11.6 ± 3.2 |
31.0 ± 2.6 |
6.0 ± 1.0 |
– |
5000 |
55.6 ± 9.4 |
8.6 ± 2.3 |
8.3 ± 0.5 |
29.6 ± 5.5 |
8.6 ± 2.8 |
Positive controls, –S9 |
Name |
SA |
SA |
4-NP |
4-NP |
9-AA |
Concentrations (μg/plate) |
2 |
2 |
40 |
40 |
80 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
266.3 ± 32.3 |
573.0 ± 32.6 |
1871.3 ± 40.8 |
968.6 ± 144.3 |
218 ± 100.9 |
|
Positive controls, –S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
5 |
2.5 |
5 |
5 |
2.5 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
56.5 ± 2.1* |
10.6 ± 1.1 |
16.6 ± 4.0 |
26.3 ± 7.2 |
7.0 ± 3.4 |
|
Negative controls, +S9 |
Culture medium and Tween 80/aqua bidest. |
84.6 ± 17.9 |
12.0 ± 2.5 |
11.3 ± 1.8 |
18.0 ± 3.5 |
7.5 ± 3.3 |
+ |
16 |
71.3 ± 2.0 |
14.0 ± 2.6 |
14.3 ± 0.5 |
22.3 ± 3.5 |
4.6 ± 2.0 |
+ |
80 |
81.3 ± 11.5 |
10.3 ± 1.5 |
9.3 ± 0.5 |
23.6 ± 2.0 |
7.0 ± 3.0 |
+ |
400 |
89.3 ± 2.0 |
13.3 ± 5.5 |
13.6 ± 4.9 |
24.0 ± 3.6 |
7.0 ± 1.7 |
+ |
1000 |
94.6 ± 12.5 |
13.0 ± 2.6 |
9.0 ± 2.0 |
22.6 ± 2.0 |
4.0 ± 2.6 |
+ |
5000 |
100.0 ± 3.6 |
15.6 ± 3.0 |
9.0 ± 1.0 |
15.0 ± 3.0 |
5.0 ± 4.0 |
Positive controls, +S9 |
Name |
SA |
SA |
4-NP |
4-NP |
9AA |
Concentrations (μg/plate) |
2 |
2 |
40 |
40 |
80 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
140.0 ± 18.7 |
20.6 ± 2.5 |
19.6 ± 2.8 |
721.3 ± 38.8 |
196.0 ± 67.6 |
|
Positive controls, +S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
5 |
2.5 |
5 |
5 |
2.5 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
1100.3 ± 55.1 |
438.0 ± 33.4 |
162.0 ± 22.5 |
884.0 ± 114.0 |
46.3 ± 9.0 |
9-AA = 9-aminoacridine
4-NP = 4-nitro-o-phenylenediamine
SA = sodium azide
2AA = 2-Aminoanthracene
* contamination of 1 plate
Table 3: Test results of experiment 2
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± SD) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA 1535 |
TA 1538 |
TA 98 |
TA 1537 |
||
Negative controls, –S9 |
Culture medium and Tween 80/aqua bidest. |
113.1± 12.7 |
9.8± 3.7 |
11.8± 3.3 |
47.6± 4.4 |
8.0± 1.0
|
– |
8 |
108.6± 7.0 |
10.0± 2.8 |
9.6± 3.7 |
48.6± 12.5 |
7.6± 3.0 |
- |
40 |
109.6± 6.4 |
9.3± 4.3 |
11.3± 0.5 |
43.3± 8.6 |
6.6± 1.1 |
- |
200 |
99.5± 6.3 |
14.6± 5.6 |
13.0± 6.0 |
47.0± 11.5 |
7.0± 2.6 |
– |
1000 |
115.0± 14.1 |
11.0± 1.1 |
12.0± 3.4 |
49.0± 7.2 |
9.0± 2.0 |
– |
5000 |
114.3± 9.2 |
6.3± 2.8 |
9.6± 2.0 |
44.0± 7.2 |
11.0± 3.6 |
Positive controls, –S9 |
Name |
SA |
SA |
4-NP |
4-NP |
9-AA |
Concentrations (μg/plate) |
2 |
2 |
40 |
40 |
80 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
645.3± 56.1 |
388.6± 15.9 |
2167.3± 101.2 |
1103.3± 162.4 |
91.0± 19.5 |
|
Positive controls, –S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
5 |
2.5 |
5 |
5 |
2.5 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
107.3± 6.6 |
7.6± 2.3 |
18.6± 8.5 |
54.6± 3.2 |
9.6± 2.5 |
|
Negative controls, +S9 |
Culture medium and Tween 80/aqua bidest. |
109.0± 10.0 |
15.1± 4.0 |
24.1± 1.9 |
61.3± 7.9 |
6.8± 2.9 |
+ |
8 |
92.3± 17.0 |
11.0± 2.6 |
27.3± 2.5 |
69.6± 14.5 |
9.6± 0.5 |
+ |
40 |
116.0± 7.0 |
12.3± 3.2 |
29.6± 1.5 |
59.3± 3.2 |
7.0± 1.7 |
+ |
200 |
104.0± 16.3 |
12.6± 4.9 |
27.0± 6.5 |
68.6± 8.0 |
7.3± 1.1 |
+ |
1000 |
118.6± 5.1 |
14.6± 5.5 |
25.3± 3.5 |
70.6± 8.0 |
7.6± 3.0 |
+ |
5000 |
113.6± 25.7 |
9.3± 3.0 |
28.6± 1.5 |
75.3± 3.2 |
12.6± 1.5 |
Positive controls, +S9 |
Name |
SA |
SA |
4-NP |
4-NP |
9AA |
Concentrations (μg/plate) |
2 |
2 |
40 |
40 |
80 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
202.0± 16.0 |
178.3± 7.6 |
1487.0± 128.0 |
736.3± 7.9 |
65.0± 15.0 |
|
Positive controls, +S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
5 |
2.5 |
5 |
5 |
2.5 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
1337.6± 47.5 |
194.6± 24.9 |
1515.0± 171.6 |
1100.6± 47.5 |
87.6± 17.6 |
9-AA = 9-aminoacridine
4-NP = 4-nitro-o-phenylenediamine
SA = sodium azide
2AA = 2-Aminoanthracene
Table 1: Cytotoxic and Genotoxic observations
Test item |
Concentration |
Mitotic Index |
Aberrant cells in % |
|
|
in µg/mL |
in % |
with gaps |
without gaps |
Exposure period 3 h, fixation time 24 h, without S9 mix |
||||
Ethanol |
1.0% (v/v) |
100 |
2 |
2 |
MMC |
0.5 |
67 |
31 |
30 |
Test substance |
3 |
99 |
1 |
1 |
10 |
98 |
2 |
2 |
|
33 |
92 |
1 |
1 |
|
Exposure period 3 h, fixation time 24 h, with S9 mix |
||||
Ethanol |
1.0% (v/v) |
100 |
1 |
1 |
CP |
0.5 |
51 |
38 |
38 |
Test substance |
3 |
101 |
1 |
1 |
10 |
108 |
0 |
0 |
|
33 |
103 |
3 |
3 |
|
Exposure period 24 h, fixation time 24 h, without S9 mix |
||||
Ethanol |
1.0% (v/v) |
100 |
1 |
1 |
MMC |
0.2 |
54 |
34 |
33 |
Test substance |
3 |
99 |
1 |
1 |
10 |
103 |
3 |
3 |
|
33 |
70 |
4 |
3 |
|
Exposure period 48 h, fixation time 48 h, without S9 mix |
||||
Ethanol |
1.0% (v/v) |
100 |
2 |
0 |
MMC |
0.1 |
120 |
51 |
49 |
Test substance |
3 |
108 |
1 |
0 |
10 |
100 |
0 |
0 |
|
33 |
99 |
2 |
2 |
|
Exposure period 3 h, fixation time 48 h, with S9 mix |
||||
Ethanol |
1.0% (v/v) |
100 |
0 |
0 |
CP |
10.0 |
-- |
44 |
44 |
Test substance |
3 |
100 |
2 |
2 |
10 |
94 |
2 |
2 |
|
33 |
97 |
1 |
0 |
MMC: Mitomycin CP: Cyclophosphamide
Table 1. Experiment 1: Cytotoxic and mutagenic response of 2-Ethylhexyl oleate in the mouse lymphoma L5178Y test system.
Dose (µg/mL) |
RSG (%) |
CEday2(%) |
RSday2 (%) |
RTG (%) |
Mutation Frequency x 10-6 |
||
Total |
Small |
Large |
|||||
|
Without metabolic activation (3-hour treatment) |
||||||
SC1 |
100 |
89 |
100 |
100 |
100 |
69 |
28 |
SC2 |
100 |
108 |
100 |
100 |
99 |
67 |
28 |
0.03 |
106 |
105 |
107 |
113 |
87 |
63 |
20 |
0.1 |
102 |
101 |
102 |
104 |
76 |
50 |
23 |
0.3 |
88 |
86 |
88 |
77 |
109 |
71 |
34 |
1 |
107 |
99 |
101 |
108 |
99 |
73 |
22 |
3 |
106 |
97 |
98 |
104 |
93 |
64 |
25 |
10 |
103 |
105 |
107 |
110 |
88 |
62 |
22 |
33 |
82 |
111 |
113 |
92 |
133 |
86 |
38 |
100(1) |
82 |
120 |
121 |
100 |
93 |
67 |
22 |
MMS |
66 |
56 |
57 |
37 |
1463 |
939 |
292 |
|
With 8% (v/v) metabolic activation (3-hour treatment) |
||||||
SC1 |
100 |
65 |
100 |
100 |
68 |
41 |
26 |
SC2 |
100 |
67 |
100 |
100 |
58 |
32 |
25 |
0.03 |
96 |
66 |
100 |
96 |
73 |
45 |
26 |
0.1 |
102 |
63 |
95 |
97 |
71 |
39 |
30 |
0.3 |
93 |
67 |
102 |
94 |
71 |
46 |
24 |
1 |
107 |
66 |
100 |
107 |
71 |
40 |
29 |
3 |
108 |
58 |
88 |
95 |
74 |
53 |
20 |
10 |
107 |
53 |
80 |
85 |
74 |
50 |
22 |
33 |
95 |
62 |
94 |
89 |
74 |
43 |
29 |
100(1) |
100 |
54 |
81 |
81 |
68 |
44 |
23 |
CP |
57 |
44 |
66 |
38 |
752 |
574 |
137 |
Note: all calculations were made without rounding off.
RSG = Relative Suspension Growth; CE = Cloning Efficiency; RS = Relative Survival; RTG = Relative Total Growth; SC = Solvent control = Ethanol; MMS Methylmethanesulfonate; CP = Cyclophosphamide.
(1) = 2-Ethylhexyl oleate precipitated in the exposure medium.
Table 2. Experiment 2: Cytotoxic and mutagenic response of 2-Ethyl oleate in the mouse lymphoma L5178Y test system.
Dose (µg/mL) |
RSG (%) |
CEday2(%) |
RSday2 (%) |
RTG (%) |
Mutation Frequency x 10-6 |
||
Total |
Small |
Large |
|||||
|
Without metabolic activation (24-hour treatment) |
||||||
SC1 |
100 |
85 |
100 |
100 |
59 |
35 |
22 |
SC2 |
100 |
93 |
100 |
100 |
63 |
35 |
26 |
0.03 |
119 |
93 |
104 |
124 |
67 |
36 |
29 |
0.1 |
134 |
91 |
103 |
138 |
56 |
34 |
21 |
0.3 |
121 |
115 |
129 |
156 |
40 |
20 |
20 |
1 |
124 |
97 |
109 |
135 |
47 |
35 |
12 |
3 |
105 |
89 |
100 |
105 |
57 |
38 |
18 |
10 |
124 |
94 |
106 |
131 |
52 |
27 |
24 |
33 |
119 |
99 |
112 |
133 |
58 |
31 |
25 |
100(1) |
129 |
97 |
109 |
140 |
44 |
28 |
15 |
MMS |
106 |
81 |
92 |
97 |
503 |
305 |
152 |
|
With 12% (v/v) metabolic activation (3-hour treatment) |
||||||
SC1 |
100 |
76 |
100 |
100 |
102 |
51 |
47 |
SC2 |
100 |
101 |
100 |
100 |
76 |
38 |
35 |
0.03 |
96 |
81 |
92 |
88 |
82 |
44 |
36 |
0.1 |
100 |
80 |
91 |
91 |
82 |
44 |
35 |
0.3 |
103 |
95 |
108 |
111 |
97 |
52 |
41 |
1 |
106 |
101 |
114 |
121 |
70 |
41 |
27 |
3 |
102 |
83 |
94 |
95 |
85 |
40 |
42 |
10 |
96 |
88 |
99 |
95 |
76 |
46 |
28 |
33 |
99 |
81 |
92 |
91 |
89 |
55 |
31 |
100(1) |
98 |
86 |
98 |
96 |
73 |
37 |
34 |
MMS |
62 |
66 |
75 |
46 |
1337 |
776 |
310 |
Table 3. Historical control data of the spontaneous mutation frequencies of the solvent controls of the mouse lymphoma assay.
|
-S9-mix |
+S9-mix |
|
3-hour treatment |
24-hour treatment |
|
|
Range |
[51-120] x 10-6 |
[50-127] x10-6 |
[50-170] x 10-6 |
Mean |
77 x 10-6 |
80 x 10-6 |
92 x 10-6 |
SD |
18 x 10-6 |
19 x10-6 |
33 x10-6 |
n |
88 |
82 |
141 |
SD = Standard deviation
n = Number of observation
The above mentioned historical control data range of the solvent controls were obtained by collecting all data of the solvent control values (media, DMSO, and ethanol) over the period of June 2006 to June 2009.
Table 4. Historical control data of the spontaneous mutation frequencies of the positive controls for the mouse lymphoma assay.
|
-S9-mix |
+S9-mix |
|
3-hour treatment |
24-hour treatment |
|
|
Range |
[518-2052] x 10-6 |
[578-1533] x10-6 |
[724-3715] x 10-6 |
Mean |
1004 x 10-6 |
1063 x 10-6 |
1597 x 10-6 |
SD |
356 x 10-6 |
232 x10-6 |
712 x10-6 |
n |
45 |
34 |
81 |
The above mentioned historical control data range of the positive controls were obtained by collecting all data over the period of June 2006 to June 2009.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Read across justification
No data on the potential for genetic toxicity of Lauryl laurate (CAS 13945-76-1) are available.
The assessment was therefore based on studies conducted with analogue substances as part of a read across approach, which is in accordance with Regulation (EC) No. 1907/2006, Annex XI, 1.5. For each specific endpoint the source substance(s) structurally closest to the target substance is/are chosen for read-across, with due regard to the requirements of adequacy and reliability of the available data. Structural similarities and similarities in properties and/or activities of the source and target substance are the basis of read-across. A detailed justification for the analogue read-across approach is provided in the technical dossier (see IUCLID Section 13).
Genetic toxicity (mutagenicity) in bacteria in vitro
CAS 2306-88-9
The mutagenic potential of Octyl octanoate (CAS 2306-88-9) was tested in a Salmonella typhimurium reverse mutation assay according to OECD guideline 471 (WoE, Ames, 2000). The following strains were used: TA 1535, TA 1537, TA 100, TA 98 and TA 102. Tester strains were incubated with the test substance up to the limit concentration of 5000 µg/plate, with and without the addition of a metabolic activation system. Experiment I was carried out as a plate incorporation assay, while experiments II and III were performed as pre-incubation assays. No cytotoxicity of the test substance was observed. The positive and negative controls were shown to be valid with and without metabolic activation. Due to slightly induced numbers of revertant colonies for strain TA 1535 without metabolic activation in the second experiment, a third experiment was carried out for strain TA 1535 under the same conditions and at concentrations of 333, 1000, 2500 and 5000 µg/plate. No relevant increase in the number of revertant colonies occurred in the repeat experiment and the effect observed in the second experiment was considered to be biologically irrelevant. Thus, the test substance was considered to be not mutagenic in bacterial cells.
CAS 135800-37-2
The mutagenic potential of Fatty acids, C8-16, 2-ethylhexyl esters (CAS 135800-37-2) was assessed in a Salmonella typhimurium reverse mutation assay performed using a protocol similar to OECD guideline 471 and under GLP conditions (WoE, Ames, 1990). Tester strains TA 1535, TA 1537, TA 1538, TA 98 and TA 100 were incubated with test material concentrations of 8, 40, 200, 100 and 5000 µg/plate in Tween 80/bidest. water with and without the addition of a metabolic activation system. Two independent experiments were performed with triplicates each. No toxicity of the test substance was observed. The positive and negative controls were shown to be valid in the presence and in the absence of metabolic activation. The test substance did not induce an increase in reversions in any of the S. typhimurium strains, with or without metabolic activation. Thus, the test substance was considered to be not mutagenic in bacterial cells.
CAS 95912-86-0
The mutagenic potential of Fatty acids, C8-10, C12-18-alkyl esters (CAS 95912-86-0) was assessed in an Ames assay, performed using a protocol similar to OECD guideline 471 and under GLP conditions (WoE, Ames, 1989). Tester strains TA 1535, TA 1537, TA 1538, TA 98 and TA 100 were incubated with 5 test substance concentrations of up to 5000 µg/plate in Tween 80/bidest water with and without metabolic activation. Two independent experiments were performed with triplicates each, applying the plate incorporation method. Cytotoxicity of the test substance was observed at 5000 µg/plate. The positive and negative controls were shown to be valid in the presence and in the absence of metabolic activation. The test substance did not induce an increase in reversions in any of the S. typhimurium strains, with or without metabolic activation. Thus, the test substance was considered to be not mutagenic in bacterial cells.
Genetic toxicity (cytogenicity) in mammalian cells in vitro
CAS 26399-02-0
The cytogenetic potential of 2-ethylhexyl oleate (CAS 26399-02-0) was assessed in an in vitro mammalian chromosome aberration test in primary human lymphocytes, performed according to OECD guideline 473 (key, CA, 2010). Duplicate cultures of human lymphocytes were evaluated for chromosome aberrations in the presence and absence of metabolic activation. In the first experiment, cells were incubated with test substance concentrations of 3, 10 and 33 µg/mL in ethanol for 3 hours with a 24 hours fixation time in the absence and presence of a metabolic activation system. In the second experiment cells were incubated with 3, 10 and 33 µg/mL for 24 hours followed by 24 hours expression time and for 48 hours following 48 hours expression time, all without metabolic activation. In the presence of metabolic activation 2-ethylhexyl oleate was also tested with 3, 10 and 33 µg/mL for 3 hours followed by 48 hours expression time. 33 µg/mL was the maximum concentration due to the limited solubility of the test substance. The highest concentration of the test substance caused modest cytotoxicity. The vehicle (solvent) and positive controls were shown to be valid. The test material did not induce a statistically significant increase in the frequency of cells with chromosome aberrations, with or without metabolic activation. Thus, the test substance was considered to be not clastogenic in mammalian cells.
Genetic toxicity (mutagenicity) in mammalian cells in vitro
CAS 26399-02-0
An in vitro mammalian cell gene mutation assay was performed with 2-ethylhexyl oleate (CAS 26399-02-0) according to OECD guideline 476 (key, MLA, 2010). Two independent experiments (with 3 or 24 hours of exposure) were performed in mouse lymphoma L5178Y cells in the absence and presence of metabolic activation (S9-mix) with test substance concentrations up to 100 μg/mL dissolved in ethanol. Precipitation was seen at concentrations of 100 µg/mL and higher. The positive and negative controls were valid and within the range of historical control data. No significant increase in mutation frequency was observed. Thus, the test substance was considered to be not mutagenic in mammalian cells.
Overall conclusion for genetic toxicity
There are no available studies on the genetic toxicity of the target substanceLauryl laurate. Therefore analogue read-across from source substances was applied from in vitro studies on cytogenicity, and in vitro studies on gene mutation in bacterial cells and mammalian cells. The results of the available in vitro studies were consistently negative. Based on the available data and following the analogue approach, absence of mutagenic or clastogenic potential in vitro can be anticipated for Lauryl laurate.
Justification for classification or non-classification
According to Article 13 of Regulation (EC) No. 1907/2006 "General Requirements for Generation of Information on Intrinsic Properties of substances", information on intrinsic properties of substances may be generated by means other than tests e.g. from information from structurally related substances (grouping or read-across), provided that conditions set out in Annex XI are met. Annex XI, "General rules for adaptation of this standard testing regime set out in Annexes VII to X” states that “substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity may be considered as a group, or ‘category’ of substances. This avoids the need to test every substance for every endpoint". Since the analogue concept is applied to Lauryl laurate (CAS 13945-76-1), data will be generated from data for reference source substance(s) to avoid unnecessary animal testing. Additionally, once the analogue read-across concept is applied, substances will be classified and labelled on this basis.
Therefore, based on the analogue read-across approach, the available data on genetic toxicity do not meet the classification criteria according to Regulation (EC) 1272/2008 and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.